Heat-inactivated vaccine HID39 against Streptococcus pneumoniae infections in mice
|更新时间:2025-01-15
|
Heat-inactivated vaccine HID39 against Streptococcus pneumoniae infections in mice
Journal of Army Medical UniversityVol. 33, Issue 5, Pages: 485-488(2011)
作者机构:
1. 重庆医科大学医学检验系,临床检验诊断学教育部重点实验室
2. 重庆市药品检验所
作者简介:
基金信息:
DOI:
CLC:R378.12;R392.7;R563.1
Published:2011,
Published Online:15 March 2011,
稿件说明:
移动端阅览
YAO RUN, JIANG XUEMEI, YAN WENJUAN, et al. Heat-inactivated vaccine HID39 against Streptococcus pneumoniae infections in mice. [J]. Journal of army medical university, 2011, 33(5): 485-488.
DOI:
YAO RUN, JIANG XUEMEI, YAN WENJUAN, et al. Heat-inactivated vaccine HID39 against Streptococcus pneumoniae infections in mice. [J]. Journal of army medical university, 2011, 33(5): 485-488.DOI:
Heat-inactivated vaccine HID39 against Streptococcus pneumoniae infections in mice
effective and easy to produce. The efficacy of this vaccine will be approached in BALB/c mice. Methods HID39 was a heat-inactivated vaccine candidate origin from standard strain D39
which lost virulence but kept immunogenesis. Mice were divided into negative group
subcutaneous group and intranasal group
and were vaccinated HID39. Antibodies and subclasses were detected by ELISA. And mice were challenged with different strains to evaluate the effect of vaccine. R
esults After immunization with HID39
the mice had the serum IgG titers reaching 12 800±8 744 in subcutaneous group and 4 032±1 652 in intranasal group
while their saliva IgA titers reaching 400±197 in the later group but undetectable in the former group. IgG1
IgG2a and IgG2b were the main antibody subclasses and IgG3 was undetectable. The colonization of TIGR4 in the nasal
lung and brain were significantly decreased
and there were the least amount of nasal immunity. Importantly
this vaccine candidate provided efficient active protection against fetal intranasal and intraperitoneal infections with D39 strain and 2 clinical strains of serotype 6B and 3. The survival percent of intranasally immunized mice was about 50%
and the survival percent of passive protection of antibody was more than 50%. Conclusion HID39 is a successful vaccine and can induce immune response against pneumococcal infections in mice.
Operating Room, 2Department of Cardiovascular Surgery, 3Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University
Department of Infectious Diseases, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Pathogenic Biology, 2Department of Medical Genetics, College of Basic Medical Sciences, Army Medical University (Third Military Medical University)